Evidence map›Paper›PMID 40328727›Full record

ArticleNature communications2025

Author Correction: Targeting senescent hepatocytes for treatment of metabolic dysfunction-associated steatotic liver disease and multi-organ dysfunction.

Kuo Du, David S Umbaugh, Liuyang Wang, Ji Hye Jun, Rajesh K Dutta, Seh Hoon Oh, Niansheng Ren, Qiaojuan Zhang, Dennis C Ko, Ana Ferreira and 7 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. [Research progress on cellular senescence and liver diseases].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Kuo DuDepartment of Medicine, Duke University, Durham, NC, USA. kuo.du@duke.edu.ORCID http://orcid.org/0000-0002-1446-4653
David S UmbaughDepartment of Medicine, Duke University, Durham, NC, USA.ORCID http://orcid.org/0000-0002-5327-9020
Liuyang WangDepartment of Molecular Genetics and Microbiology, Duke University, Durham, NC, USA.
Ji Hye JunDepartment of Medicine, Duke University, Durham, NC, USA.
Rajesh K DuttaDepartment of Medicine, Duke University, Durham, NC, USA.
Seh Hoon OhDepartment of Medicine, Duke University, Durham, NC, USA.
Niansheng RenDepartment of Medicine, Duke University, Durham, NC, USA.
Qiaojuan ZhangDepartment of Neurology, Duke University, Durham, NC, USA.
Dennis C KoDepartment of Molecular Genetics and Microbiology, Duke University, Durham, NC, USA.ORCID http://orcid.org/0000-0002-0113-5981
Ana FerreiraBoehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA.
Jon HillBoehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA.ORCID http://orcid.org/0000-0003-1592-6482
Guannan GaoBoehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA.
Steven S PullenBoehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA.
Vaibhav JainDuke Molecular Physiology Institute, Duke University, Durham, NC, USA.
Simon GregoryDuke Molecular Physiology Institute, Duke University, Durham, NC, USA.ORCID http://orcid.org/0000-0002-7805-1743
Manal F AbdelmalekDepartment of Medicine, Mayo Clinic, Rochester, MN, USA.
Anna Mae DiehlDepartment of Medicine, Duke University, Durham, NC, USA. annamae.diehl@duke.edu.ORCID http://orcid.org/0000-0003-1859-089X

Funding

Targeting Hepatocyte Senescence to Improve NAFLDK01DK135793 · NIDDK · DUKE UNIVERSITY · PI Kuo Du · 2024 to 2026
$433k
NIDDK NIH HHS K01 DK135793
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40328727
PMCPMC12056051

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.